A recent study indicates that patients who discontinue blockbuster weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass far faster than those who stop conventional lifestyle regimens.
Published data in a leading medical journal shows that while overweight people often shed substantial amounts of their body weight while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month once they quit.
"Users using these treatments need to be aware of the danger of rapid rebound weight gain when the medication concludes," cautioned researcher Dr. Susan Jebb.
Such speed of recovery means a reversion to starting mass within about a year and a half.
Analyzing Therapies
The research, which examined dozens of trials involving thousands of participants, compared the outcomes of GLP-1 agonists with older methods.
Researchers emphasize that individuals who lose weight through lifestyle changes alone generally experience a slower weight regain—approximately 100 grams monthly—post-intervention.
The Reason for the Fast Rebound
Experts suggest the mechanism of the jabs is key to understanding the heightened weight return.
GLP-1 drugs copy a body's own chemical called glucagon-like peptide-1, which moderates hunger.
"Sustained high doses of GLP-1 concentrations far above than the body's typical production may cause the body to generate a reduced amount of its own natural hormone, and may also lessen responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this GLP-1 'fix' means appetite is uncontrolled, making excessive eating much more probable."
A Lifelong Condition?
Health authorities recommend the injections for individuals with weight-linked health risks, accompanied by recommended diet and exercise modifications.
Many experts say that, due to the likelihood of weight regain, the treatment might need to be life-long.
This perspective is reinforced by pharmaceutical companies, who state that the results "underscore the persistent nature of excess weight," akin to managing conditions like diabetes.
User Testimonies
People who have discontinued the medication report a sudden return of cravings.
"It felt as if a trigger flipping and you're instantly starving," described one woman.
This difficulty is compounded if patients have not established sustainable lifestyle or habit modifications during treatment.
Widespread Adoption
Survey data show that a significant number of adults in the UK have tried weight-loss jabs in the past year, with interest continuing to grow.
- Adoption is higher among women than men.
- The middle-aged demographic shows the greatest usage rates.
- Many access the medications through private healthcare rather than the NHS.
In conclusion, experts caution that while GLP-1 drugs are powerful tools for shedding pounds, they are not a standalone solution and lasting health benefits hinges on ongoing lifestyle management.
